An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
Clinical trial NCT03599622 · TERMINATED
Trial details
- NCT number
- NCT03599622
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-16
- Primary completion
- 2022-12-12
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.